Jurak
Ferenc Jurak, Budapest HU
Patent application number | Description | Published |
---|---|---|
20130296353 | CRYSTALLINE PHARMACEUTICALLY ACTIVE INGREDIENTS - The present invention is related to crystalline forms of rosuvastatin zinc (2:1) salt. The polymorphs are suitable for use as pharmaceutically active ingredients in the treatment of the diseases of the lipid metabolism including hypercholesterolemia, hyperlipidemia, dyslipidemia or atherosclerosis. | 11-07-2013 |
Igor Jurak, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110118332 | VIRAL MICRORNA - The present invention relates, in general, to micro RN As and. in particular, to viral microRNAs expressed by Herpes Simplex Vims 1 (HSV-1) or Herpes Simplex Virus 2 (HSV-2), to agents that inhibit such microRNAs and to methods of treatment based on the use of such agents. | 05-19-2011 |
Marek Jurak, Zlin CZ
Patent application number | Description | Published |
---|---|---|
20140145436 | FEED-THROUGH DEVICE - A device for a sealed feed-through of an elongated part through an opening in a mounting wall includes a hollow cylindrical tubular fitting connectable to the mounting wall and having a fitting channel for the elongated part and a first outer thread, a cap nut with a feed-through opening for the elongated part and an inner cap thread that is connected to the first outer thread, and a sealing member arranged within the cap nut and having a receiving channel for the elongated part. The tubular fitting includes, adjacent the first outer thread, a cylindrical sealing wall and the cap nut includes, adjacent to the inner cap thread, a closing flange that holds an elastic sealing ring that rests tightly sealing on the sealing wall and which is axially movable along the sealing wall when the cap nut is turned relative to the tubular fitting. | 05-29-2014 |
Pavel Jurak, Brno CZ
Patent application number | Description | Published |
---|---|---|
20100174203 | METHOD OF VENTRICULAR REPOLARIZATION ANALYSIS - While analyzing ventricular repolarization in accordance with the invention, ECG measurement with excitation of heart rate is evaluated and the coupling of an internal parameter, for example QT to heartbeat interval, for example RR, is modeled by a transfer function with three parameters. The values of the resulting five parameters describing the static and dynamic characteristics of ventricular repolarization are obtained by means of transfer function parameters and the measured values of heart rate and the internal parameter. The effect of medication is evaluated from the difference of the values of these parameters determined before and after administrating the medication. | 07-08-2010 |
20110237966 | Device for Blood Flow Property Measurement and Method of its Connection - The device for blood flow property measurement in the body and the method of its connection to the subject enables to measure electrical impedance in the main parts of body simultaneously. The impedance is spatially localized in the particular scanning channels ( | 09-29-2011 |
Steven J. Jurak, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140193296 | APPARATUS AND METHODS FOR OZONE GENERATION AND DEGRADATION - Devices and methods for sterilizing an enclosed space using ozone are disclosed herein. Various embodiments of the devices and methods also provide for accelerated degradation of the ozone upon sterilization. In some embodiments, a disclosed sterilization unit includes a first housing defining an ozone generation cavity, an ozone generator disposed within the ozone generation cavity, a second housing defining an ozone degradation cavity, and an ozone degrader disposed within the ozone degradation cavity. The sterilization unit of various embodiments is configured to cycle air between the enclosed space and the ozone generation cavity during an ozone generation cycle to sterilize the enclosed space; similarly, the unit is further configured to cycle air between the enclosed space and the ozone degradation cavity during an ozone degradation cycle to return the air within the enclosed space to safe ozone levels. | 07-10-2014 |